Chromatin profiling reveals regulatory network shifts and a protective role for hepatocyte nuclear factor 4α during colitis

Molecular and Cellular Biology

Volumn 34, Issue 17, 2014, Pages 3291-3304

  Chahar, Sanjay ^a   Gandhi, Vishal ^a   Yu, Shiyan ^b   Desai, Kinjal ^e   Cowper Sallari, Richard ^f   Kim, Yona ^a   Perekatt, Ansu O ^a   Kumar, Namit ^a   Thackray, Joshua K ^a   Musolf, Anthony ^a   Kumar, Nikhil ^a   Hoffman, A ^a   Londono, Douglas ^a   Vazquez, Berta N ^a   Serrano, Lourdes ^a   Shin, Hyunjin ^d   Lupien, Mathieu ^f,g,h   Gao, Nan ^b,c   Verzi, Michael P ^a,c  

^a Life Sciences Building Rutgers University   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^d TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

^e DARTMOUTH MEDICAL SCHOOL   (United States)

^f PRINCESS MARGARET HOSPITAL   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

^h ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 4ALPHA; CHROMATIN; DEXTRAN SULFATE; HEPATOCYTE NUCLEAR FACTOR 4; HNF4A PROTEIN, HUMAN; HNF4A PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CACO 2 CELL LINE; CHROMATIN; CHROMATIN STRUCTURE; COLON MUCOSA; CONTROLLED STUDY; DISEASE PREDISPOSITION; DOWN REGULATION; ENHANCER REGION; EPIGENETICS; EXPERIMENTAL COLITIS; FEMALE; GENE EXPRESSION REGULATION; GENE MAPPING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATOR GENE; TRANSCRIPTION REGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; COLITIS; DISEASE MODEL; GENE INACTIVATION; GENE REGULATORY NETWORK; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; INFLAMMATORY BOWEL DISEASE; INTESTINE MUCOSA; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; REGULATORY SEQUENCE;

ANIMALS; BINDING SITES; CACO-2 CELLS; CHROMATIN; COLITIS; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; EPIGENESIS, GENETIC; FEMALE; GENE KNOCKOUT TECHNIQUES; GENE REGULATORY NETWORKS; GENETIC PREDISPOSITION TO DISEASE; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REGULATORY ELEMENTS, TRANSCRIPTIONAL;

EID: 84925581406     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00349-14     Document Type: Article

References (71)

1. Henderson P, van Limbergen JE, Schwarze J, Wilson DC. 2011. Function of the intestinal epithelium and its dysregulation in inflammatory bowel disease. Inflamm. Bowel Dis. 17:382-395. http://dx.doi.org/10.1002/ibd.21379.
2. Pastorelli L, De Salvo C, Mercado JR, Vecchi M, Pizarro TT. 2013. Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics. Front. Immunol. 4:280. http://dx.doi.org/10.3389/fimmu.2013.00280.
3. Zimmerman NP, Vongsa RA, Wendt MK, Dwinell MB. 2008. Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease. Inflamm. Bowel Dis. 14:1000-1011. http://dx.doi.org/10.1002/ibd.20480.
4. Heintzman ND, Hon GC, Hawkins RD, Kheradpour P, Stark A, Harp LF, Ye Z, Lee LK, Stuart RK, Ching CW, Ching KA, Antosiewicz-Bourget JE, Liu H, Zhang X, Green RD, Lobanenkov VV, Stewart R, Thomson JA, Crawford GE, Kellis M, Ren B. 2009. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459:108-112. http://dx.doi.org/10.1038/nature07829.
5. Rada-Iglesias A, Bajpai R, Swigut T, Brugmann SA, Flynn RA, Wysocka J. 2011. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470:279-283. http://dx.doi.org/10.1038/nature09692.
6. Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, Steine EJ, Hanna J, Lodato MA, Frampton GM, Sharp PA, Boyer LA, Young RA, Jaenisch R. 2010. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl. Acad. Sci. U. S. A. 107:21931-21936. http://dx.doi.org/10.1073/pnas.1016071107.
7. Zentner GE, Tesar PJ, Scacheri PC. 2011. Epigenetic signatures distinguish multiple classes of enhancers with distinct cellular functions. Genome Res. 21:1273-1283. http://dx.doi.org/10.1101/gr.122382.111.
8. He HH, Meyer CA, Shin H, Bailey ST, Wei G, Wang Q, Zhang Y, Xu K, Ni M, Lupien M, Mieczkowski P, Lieb JD, Zhao K, Brown M, Liu XS. 2010 Nucleosome dynamics define transcriptional enhancers. Nat. Genet. 42:343-347. http://dx.doi.org/10.1038/ng.545.
9. Verzi MP, Shin H, He HH, Sulahian R, Meyer CA, Montgomery RK, Fleet JC, Brown M, Liu XS, Shivdasani RA. 2010. Differentiationspecific histone modifications reveal dynamic chromatin interactions and partners for the intestinal transcription factor CDX2. Dev. Cell 19:713-726 http://dx.doi.org/10.1016/j.devcel.2010.10.006.
10. Abdelbaqi M, Chidlow JH, Matthews KM, Pavlick KP, Barlow SC, Linscott AJ, Grisham MB, Fowler MR, Kevil CG. 2006. Regulation of dextran sodium sulfate induced colitis by leukocyte beta 2 integrins. Lab. Invest. 86:380-390. http://dx.doi.org/10.1038/labinvest.3700398.
11. Laroui H, Ingersoll SA, Liu HC, Baker MT, Ayyadurai S, Charania MA, Laroui F, Yan Y, Sitaraman SV, Merlin D. 2012. Dextran sodium sulfate (DSS) induces colitis in mice by forming nano-lipocomplexes with medium-chain-length fatty acids in the colon. PLoS One 7:e32084. http://dx.doi.org/10.1371/journal.pone.0032084.
12. Ortega-Cava CF, Ishihara S, Rumi MA, Kawashima K, Ishimura N, Kazumori H, Udagawa J, Kadowaki Y, Kinoshita Y. 2003. Strategic compartmentalization of Toll-like receptor 4 in the mouse gut. J. Immunol. 170:3977-3985. http://dx.doi.org/10.4049/jimmunol.170.8.3977.
13. Verzi MP, Shin H, Ho LL, Liu XS, Shivdasani RA. 2011. Essential and redundant functions of caudal family proteins in activating adult intestinal genes. Mol. Cell. Biol. 31:2026-2039. http://dx.doi.org/10.1128/MCB.01250-10.
14. Verzi MP, Shin H, San Roman AK, Liu XS, Shivdasani RA. 2013. Intestinal master transcription factor CDX2 controls chromatin access for partner transcription factor binding. Mol. Cell. Biol. 33:281-292. http://dx.doi.org/10.1128/MCB.01185-12.
15. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nussbaum C, Myers RM, Brown M, Li W, Liu XS. 2008. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9:R137. http://dx.doi.org/10.1186/gb-2008-9-9-r137.
16. Zhang Y, Shin H, Song JS, Lei Y, Liu XS. 2008. Identifying positioned nucleosomes with epigenetic marks in human from ChIP-Seq. BMC Genomics 9:537. http://dx.doi.org/10.1186/1471-2164-9-537.
17. Meyer CA, He HH, Brown M, Liu XS. 2011. BINOCh: binding inference from nucleosome occupancy changes. Bioinformatics 27:1867-1868. http://dx.doi.org/10.1093/bioinformatics/btr279.
18. McLean CY, Bristor D, Hiller M, Clarke SL, Schaar BT, Lowe CB, Wenger AM, Bejerano G. 2010. GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol. 28:495-501. http://dx.doi.org/10.1038/nbt.1630.
19. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 102:15545-15550. http://dx.doi.org/10.1073/pnas.0506580102.
20. Fang K, Bruce M, Pattillo CB, Zhang S, Stone R, II, Clifford J, Kevil CG. 2011 Temporal genomewide expression profiling of DSS colitis reveals novel inflammatory and angiogenesis genes similar to ulcerative colitis. Physiol. Genomics 43:43-56. http://dx.doi.org/10.1152/physiolgenomics.00138.2010.
21. Li C, Wong WH. 2001. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc. Natl. Acad. Sci. U. S. A. 98:31-36. http://dx.doi.org/10.1073/pnas.98.1.31.
22. Darsigny M, Babeu JP, Dupuis AA, Furth EE, Seidman EG, Levy E, Verdu EF, Gendron FP, Boudreau F. 2009. Loss of hepatocyte-nuclearfactor-4α affects colonic ion transport and causes chronic inflammation resembling inflammatory bowel disease in mice. PLoS One 4:e7609. http://dx.doi.org/10.1371/journal.pone.0007609.
23. Liu T, Ortiz JA, Taing L, Meyer CA, Lee B, Zhang Y, Shin H, Wong SS, Ma J, Lei Y, Pape UJ, Poidinger M, Chen Y, Yeung K, Brown M, Turpaz Y, Liu XS. 2011. Cistrome: an integrative platform for transcriptional regulation studies. Genome Biol. 12:R83. http://dx.doi.org/10.1186/gb-2011-12-8-r83.
24. Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, Getz G, Mesirov JP. 2011. Integrative genomics viewer. Nat. Biotechnol. 29:24-26. http://dx.doi.org/10.1038/nbt.1754.
25. Akhtar-Zaidi B, Cowper-Sal-Lari, Corradin RO, Saiakhova A, Bartels CF, Balasubramanian D, Myeroff L, Lutterbaugh J, Jarrar A, Kalady MF, Willis J, Moore JH, Tesar PJ, Laframboise T, Markowitz S, Lupien M, Scacheri PC. 2012. Epigenomic enhancer profiling defines a signature of colon cancer. Science 336:736-739. http://dx.doi.org/10.1126/science.1217277.
26. Cowper-Sallari R, Zhang X, Wright JB, Bailey SD, Cole MD, Eeckhoute J, Moore JH, Lupien M. 2012. Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression. Nat. Genet. 44:1191-1198. http://dx.doi.org/10.1038/ng.2416.
27. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. 1990 A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98:694-702.
28. Oettgen P. 2006. Regulation of vascular inflammation and remodeling by ETS factors. Circ. Res. 99:1159-1166. http://dx.doi.org/10.1161/01.RES.0000251056.85990.db.
29. Oliver JR, Kushwah R, Hu J. 2012. Multiple roles of the epitheliumspecific ETS transcription factor, ESE-1, in development and disease. Lab. Invest. 92:320-330. http://dx.doi.org/10.1038/labinvest.2011.186.
30. Schonthaler HB, Guinea-Viniegra J, Wagner EF. 2011. Targeting inflammation by modulating the Jun/AP-1 pathway. Ann. Rheum. Dis. 70(Suppl 1):i109-i112. http://dx.doi.org/10.1136/ard.2010.140533.
31. Wang A, Al-Kuhlani M, Johnston SC, Ojcius DM, Chou J, Dean D. 2013 Transcription factor complex AP-1 mediates inflammation initiated by Chlamydia pneumoniae infection. Cell. Microbiol. 15:779-794. http://dx.doi.org/10.1111/cmi.12071.
32. Zingarelli B, Hake PW, Burroughs TJ, Piraino G, O'Connor M, Denenberg A. 2004. Activator protein-1 signalling pathway and apoptosis are modulated by poly(ADP-ribose) polymerase-1 in experimental colitis. Immunology 113:509-517. http://dx.doi.org/10.1111/j.1365-2567.2004.01991.x.
33. Babeu JP, Darsigny M, Lussier CR, Boudreau F. 2009. Hepatocyte nuclear factor 4α contributes to an intestinal epithelial phenotype in vitro and plays a partial role in mouse intestinal epithelium differentiation. Am. J. Physiol. Gastrointest. Liver Physiol. 297:G124-G134. http://dx.doi.org/10.1152/ajpgi.90690.2008.
34. D'Angelo A, Bluteau O, Garcia-Gonzalez MA, Gresh L, Doyen A, Garbay S, Robine S, Pontoglio M. 2010. Hepatocyte nuclear factor 1α and β control terminal differentiation and cell fate commitment in the gut epithelium. Development 137:1573-1582. http://dx.doi.org/10.1242/dev.044420.
35. Katz JP, Perreault N, Goldstein BG, Actman L, McNally SR, Silberg DG, Furth EE, Kaestner KH. 2005. Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach. Gastroenterology 128:935-945. http://dx.doi.org/10.1053/j.gastro.2005.02.022.
36. McConnell BB, Kim SS, Bialkowska AB, Yu K, Sitaraman SV, Yang VW. 2011. Kruppel-like factor 5 protects against dextran sulfate sodiuminduced colonic injury in mice by promoting epithelial repair. Gastroenterology 140:540-549. http://dx.doi.org/10.1053/j.gastro.2010.10.061.
37. Yu T, Chen X, Zhang W, Li J, Xu R, Wang TC, Ai W, Liu C. 2012. Kruppel-like factor 4 regulates intestinal epithelial cell morphology and polarity. PLoS One 7:e32492. http://dx.doi.org/10.1371/journal.pone.0032492.
38. Ahn SH, Shah YM, Inoue J, Morimura K, Kim I, Yim S, Lambert G, Kurotani R, Nagashima K, Gonzalez FJ, Inoue Y. 2008. Hepatocyte nuclear factor 4α in the intestinal epithelial cells protects against inflammatory bowel disease. Inflamm. Bowel Dis. 14:908-920. http://dx.doi.org/10.1002/ibd.20413.
39. Tetreault MP, Alrabaa R, McGeehan M, Katz JP. 2012. Kruppel-like factor 5 protects against murine colitis and activates JAK-STAT signaling in vivo. PLoS One 7:e38338. http://dx.doi.org/10.1371/journal.pone.0038338.
40. Barrett JC, Lee JC, Lees CW, Prescott NJ, Anderson CA, Phillips A, Wesley E, Parnell K, Zhang H, Drummond H, Nimmo ER, Massey D, Blaszczyk K, Elliott T, Cotterill L, Dallal H, Lobo AJ, Mowat C, Sanderson JD, Jewell DP, Newman WG, Edwards C, Ahmad T, Mansfield JC, Satsangi J, Parkes M, Mathew CG, Donnelly P, Peltonen L, Blackwell JM, Bramon E, Brown MA, Casas JP, Corvin A, Craddock N, Deloukas P, Duncanson A, Jankowski J, Markus HS, McCarthy MI, Palmer CN, Plomin R, Rautanen A, Sawcer SJ, Samani N, Trembath RC, Viswanathan AC, Wood N, Spencer CC, Bellenguez C, Davison D, Freeman C, Strange A, Langford C, Hunt SE, Edkins S, Gwilliam R, Blackburn H, Bumpstead SJ, Dronov S, Gillman M, Gray E, Hammond N, Jayakumar A, McCann OT, Liddle J, Perez ML, Potter SC, Ravindrarajah R, Ricketts M, Waller M, Weston P, Widaa S, Whittaker P, Attwood AP, Stephens J, Sambrook J, Ouwehand WH, McArdle WL, Ring SM, Strachan DP. 2009. Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat. Genet. 41:1330-1334. http://dx.doi.org/10.1038/ng.483.
41. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, Essers J, Mitrovic M, Ning K, Cleynen I, Theatre E, Spain SL, Raychaudhuri S, Goyette P, Wei Z, Abraham C, Achkar JP, Ahmad T, Amininejad L, Ananthakrishnan AN, Andersen V, Andrews JM, Baidoo L, Balschun T, Bampton PA, Bitton A, Boucher G, Brand S, Buning C, Cohain A, Cichon S, D'Amato M, De Jong D, Devaney KL, Dubinsky M, Edwards C, Ellinghaus D, Ferguson LR, Franchimont D, Fransen K, Gearry R, Georges M, Gieger C, Glas J, Haritunians T, Hart A, Hawkey C, Hedl M, Hu X, Karlsen TH, Kupcinskas L, Kugathasan S, Latiano A, Laukens D, Lawrance IC, Lees CW, Louis E, Mahy G, Mansfield J, Morgan AR, Mowat C, Newman W, Palmieri O, Ponsioen CY, Potocnik U, Prescott NJ, Regueiro M, Rotter JI, Russell RK, Sanderson JD, Sans M, Satsangi J, Schreiber S, Simms LA, Sventoraityte J, Targan SR, Taylor KD, Tremelling M, Verspaget HW, De Vos M, Wijmenga C, Wilson DC, Winkelmann J, Xavier RJ, Zeissig S, Zhang B, Zhang CK, Zhao H, Silverberg MS, Annese V, Hakonarson H, Brant SR, Radford-Smith G, Mathew CG, Rioux JD, Schadt EE, Daly MJ, Franke A, Parkes M, Vermeire S, Barrett JC, Cho JH. 2012. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491:119-124. http://dx.doi.org/10.1038/nature11582.
42. van Sommeren S, Visschedijk MC, Festen EA, de Jong DJ, Ponsioen CY, Wijmenga C, Weersma RK. 2011. HNF4α and CDH1 are associated with ulcerative colitis in a Dutch cohort. Inflamm. Bowel Dis. 17:1714-1718. http://dx.doi.org/10.1002/ibd.21541.
43. Yang SK, Jung Y, Kim H, Hong M, Ye BD, Song K. 2011. Association of FCGR2A, JAK2 or HNF4A variants with ulcerative colitis in Koreans. Dig. Liver Dis. 43:856-861. http://dx.doi.org/10.1016/j.dld.2011.07.006.
44. Garrison WD, Battle MA, Yang C, Kaestner KH, Sladek FM, Duncan SA. 2006. Hepatocyte nuclear factor 4α is essential for embryonic development of the mouse colon. Gastroenterology 130:1207-1220. http://dx.doi.org/10.1053/j.gastro.2006.01.003.
45. Cattin AL, Le Beyec J, Barreau F, Saint-Just S, Houllier A, Gonzalez FJ, Robine S, Pincon-Raymond M, Cardot P, Lacasa M, Ribeiro A. 2009. Hepatocyte nuclear factor 4α, a key factor for homeostasis, cell architec-ture, and barrier function of the adult intestinal epithelium. Mol. Cell. Biol. 29:6294-6308. http://dx.doi.org/10.1128/MCB.00939-09.
46. Verzi MP, Hatzis P, Sulahian R, Philips J, Schuijers J, Shin H, Freed E, Lynch JP, Dang DT, Brown M, Clevers H, Liu XS, Shivdasani RA. 2010. TCF4 and CDX2, major transcription factors for intestinal function, converge on the same cis-regulatory regions. Proc. Natl. Acad. Sci. U. S. A. 107:15157-15162. http://dx.doi.org/10.1073/pnas.1003822107.
47. Marcil V, Seidman E, Sinnett D, Boudreau F, Gendron FP, Beaulieu JF, Menard D, Precourt LP, Amre D, Levy E. 2010. Modification in oxidative stress, inflammation, and lipoprotein assembly in response to hepatocyte nuclear factor 4α knockdown in intestinal epithelial cells. J. Biol. Chem. 285:40448-40460. http://dx.doi.org/10.1074/jbc.M110.155358.
48. Bolotin E, Liao H, Ta TC, Yang C, Hwang-Verslues W, Evans JR, Jiang T, Sladek FM. 2010. Integrated approach for the identification of human hepatocyte nuclear factor 4α target genes using protein binding microarrays. Hepatology 51:642-653. http://dx.doi.org/10.1002/hep.23357.
49. Eckmann L, Nebelsiek T, Fingerle AA, Dann SM, Mages J, Lang R, Robine S, Kagnoff MF, Schmid RM, Karin M, Arkan MC, Greten FR. 2008 Opposing functions of IKKβ during acute and chronic intestinal inflammation. Proc. Natl. Acad. Sci. U. S. A. 105:15058-15063. http://dx.doi.org/10.1073/pnas.0808216105.
50. Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ, Kagnoff MF, Karin M. 2004. IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118:285-296. http://dx.doi.org/10.1016/j.cell.2004.07.013.
51. Kajino-Sakamoto R, Inagaki M, Lippert E, Akira S, Robine S, Matsumoto K, Jobin C, Ninomiya-Tsuji J. 2008. Enterocyte-derived TAK1 signaling prevents epithelium apoptosis and the development of ileitis and colitis. J. Immunol. 181:1143-1152. http://dx.doi.org/10.4049/jimmunol.181.2.1143.
52. Nenci A, Becker C, Wullaert A, Gareus R, van Loo G, Danese S, Huth M, Nikolaev A, Neufert C, Madison B, Gumucio D, Neurath MF, Pasparakis M. 2007. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446:557-561. http://dx.doi.org/10.1038/nature05698.
53. Steinbrecher KA, Harmel-Laws E, Sitcheran R, Baldwin AS. 2008. Loss of epithelial RelA results in deregulated intestinal proliferative/apoptotic homeostasis and susceptibility to inflammation. J. Immunol. 180:2588-2599 http://dx.doi.org/10.4049/jimmunol.180.4.2588.
54. el Marjou F, Janssen KP, Chang BH, Li M, Hindie V, Chan L, Louvard D, Chambon P, Metzger D, Robine S. 2004. Tissue-specific and inducible Cre-mediated recombination in the gut epithelium. Genesis 39:186-193 http://dx.doi.org/10.1002/gene.20042.
55. Hayhurst GP, Lee YH, Lambert G, Ward JM, Gonzalez FJ. 2001. Hepatocyte nuclear factor 4α (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol. Cell. Biol. 21:1393-1403. http://dx.doi.org/10.1128/MCB.21.4.1393-1403.2001.
56. Ernst J, Kheradpour P, Mikkelsen TS, Shoresh N, Ward LD, Epstein CB, Zhang X, Wang L, Issner R, Coyne M, Ku M, Durham T, Kellis M, Bernstein BE. 2011. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 473:43-49. http://dx.doi.org/10.1038/nature09906.
57. Karczewski KJ, Dudley JT, Kukurba KR, Chen R, Butte AJ, Montgomery SB, Snyder M. 2013. Systematic functional regulatory assessment of disease-associated variants. Proc. Natl. Acad. Sci. U. S. A. 110:9607-9612. http://dx.doi.org/10.1073/pnas.1219099110.
58. Pomerantz MM, Ahmadiyeh N, Jia L, Herman P, Verzi MP, Doddapaneni H, Beckwith CA, Chan JA, Hills A, Davis M, Yao K, Kehoe SM, Lenz HJ, Haiman CA, Yan C, Henderson BE, Frenkel B, Barretina J, Bass A, Tabernero J, Baselga J, Regan MM, Manak JR, Shivdasani R, Coetzee GA, Freedman ML. 2009. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat. Genet. 41:882-884. http://dx.doi.org/10.1038/ng.403.
59. Schaub MA, Boyle AP, Kundaje A, Batzoglou S, Snyder M. 2012. Linking disease associations with regulatory information in the human genome. Genome Res. 22:1748-1759. http://dx.doi.org/10.1101/gr.136127.111.
60. Mokry M, Middendorp S, Wiegerinck CL, Witte M, Teunissen H, Meddens CA, Cuppen E, Clevers H, Nieuwenhuis EE. 2013. Many inflammatory bowel disease risk loci include regions that regulate gene expression in immune cells and the intestinal epithelium. Gastroenterology 146:1040-1047. http://dx.doi.org/10.1053/j.gastro.2013.12.003.
61. Mizutani A, Koinuma D, Tsutsumi S, Kamimura N, Morikawa M, Suzuki HI, Imamura T, Miyazono K, Aburatani H. 2011. Cell typespecific target selection by combinatorial binding of Smad2/3 proteins and hepatocyte nuclear factor 4α in HepG2 cells. J. Biol. Chem. 286:29848-29860 http://dx.doi.org/10.1074/jbc.M110.217745.
62. Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, Murray HL, Volkert TL, Schreiber J, Rolfe PA, Gifford DK, Fraenkel E, Bell GI, Young RA. 2004. Control of pancreas and liver gene expression by HNF transcription factors. Science 303:1378-1381. http://dx.doi.org/10.1126/science.1089769.
63. Schmidt D, Wilson MD, Ballester B, Schwalie PC, Brown GD, Marshall A, Kutter C, Watt S, Martinez-Jimenez CP, Mackay S, Talianidis I, Flicek P, Odom DT. 2010. Five-vertebrate ChIP-seq reveals the evolutionary dynamics of transcription factor binding. Science 328:1036-1040. http://dx.doi.org/10.1126/science.1186176.
64. Snyder EL, Watanabe H, Magendantz M, Hoersch S, Chen TA, Wang DG, Crowley D, Whittaker CA, Meyerson M, Kimura S, Jacks T. 2013. Nkx2-1 represses a latent gastric differentiation program in lung adenocarcinoma. Mol. Cell 50:185-199. http://dx.doi.org/10.1016/j.molcel.2013.02.018.
65. Wallerman O, Motallebipour M, Enroth S, Patra K, Bysani MS, Komorowski J, Wadelius C. 2009. Molecular interactions between HNF4a, FOXA2 and GABP identified at regulatory DNA elements through ChIP-sequencing. Nucleic Acids Res. 37:7498-7508. http://dx.doi.org/10.1093/nar/gkp823.
66. Lussier CR, Babeu JP, Auclair BA, Perreault N, Boudreau F. 2008. Hepatocyte nuclear factor-4α promotes differentiation of intestinal epithelial cells in a coculture system. Am. J. Physiol. Gastrointest. Liver Physiol. 294:G418-G428. http://dx.doi.org/10.1152/ajpgi.00418.2007.
67. Hatziapostolou M, Polytarchou C, Aggelidou E, Drakaki A, Poultsides GA, Jaeger SA, Ogata H, Karin M, Struhl K, Hadzopoulou-Cladaras M, Iliopoulos D. 2011. An HNF4α-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis. Cell 147:1233-1247. http://dx.doi.org/10.1016/j.cell.2011.10.043.
68. Azmi AS, Bao GW, Gao J, Mohammad RM, Sarkar FH. 2013. Network insights into the genes regulated by hepatocyte nuclear factor 4 in response to drug induced perturbations: a review. Curr. Drug Discov. Technol. 10:147-154. http://dx.doi.org/10.2174/1570163811310020007.
69. Hwang-Verslues WW, Sladek FM. 2010. HNF4α-role in drug metabolism and potential drug target? Curr. Opin. Pharmacol. 10:698-705. http://dx.doi.org/10.1016/j.coph.2010.08.010.
70. Yuan X, Ta TC, Lin M, Evans JR, Dong Y, Bolotin E, Sherman MA, Forman BM, Sladek FM. 2009. Identification of an endogenous ligand bound to a native orphan nuclear receptor. PLoS One 4:e5609. http://dx.doi.org/10.1371/journal.pone.0005609.
71. Dudley JT, Sirota M, Shenoy M, Pai RK, Roedder S, Chiang AP, Morgan AA, Sarwal MM, Pasricha PJ, Butte AJ. 2011. Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease. Sci. Transl. Med. 3:96ra76. http://dx.doi.org/10.1126/scitranslmed.3002648.